George Christman Jr., MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 90 Ter Heun Drive, Suite 300, Falmouth, MA 02540 Phone: 508-540-0604 Fax: 508-457-0129 |
David Ralph Urbach, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 90 Ter Heun Drive, Suite 300, Falmouth, MA 02540 Phone: 508-540-0604 Fax: 508-457-0129 |
Dr. John C Hostetter, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 90 Ter Heun Dr, Suite 300, Falmouth, MA 02540 Phone: 508-540-0604 Fax: 508-457-0129 |
John J Guerin, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 90 Ter Heun Dr, Suite 300, Falmouth, MA 02540 Phone: 508-540-0604 Fax: 508-457-0129 |
Dr. Thomas Sbarra, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 90 Ter Heun Dr, Suite 300, Falmouth, MA 02540 Phone: 508-540-0604 Fax: 508-457-0129 |
Jennifer H Ladner, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 90 Ter Heun Drive, Suite 300, Falmouth, MA 02540 Phone: 508-540-0604 Fax: 508-457-0129 |
Bruce Farrell Levy, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 90 Ter Heun Dr, Suite 300, Falmouth, MA 02540 Phone: 508-540-0604 Fax: 508-457-0129 |
News Archive
One of the first researchers to study the deadly link between cardiovascular disease and diabetes will receive an American Heart Association lifetime achievement award today at a ceremony in Washington, D.C. The award presented to University of Missouri endocrinologist James Sowers, MD, recognizes his more than 30 years of accomplishments as a physician, scientist and educator.
A potentially game-changing treatment for people with, or at risk of, blood clots has been found effective by an international team of researchers led by McMaster University's Jeffrey Weitz.
"The Global Fund to Fight AIDS, Tuberculosis and Malaria on Thursday launched a new funding model that allows it to invest more strategically, achieve greater impact, and engage implementers and partners more effectively," a Global Fund press release reports.
Celldex Therapeutics, Inc. today reported financial results for the second quarter ended June 30, 2011. Celldex reported a net loss of $10.2 million, or $0.27 per share, for the second quarter of 2011 compared to a net loss of $9.5 million, or $0.30 per share, for the second quarter of 2010.
› Verified 1 days ago